Bristol-Myers Squibb buy Bank of America Co.
Start price
15.12.25
/
50%
€45.99
Target price
15.12.26
€51.96
Performance (%)
11.22%
Price
17.04.26
€51.15
Summary
This prediction is currently active. The prediction currently has a performance of 11.22%. This prediction currently runs until 15.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 2.341% | 2.341% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $61.00 price target on the stock, up previously from $52.00.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€51.00
09.04.26
09.04.26
€57.45
09.04.27
09.04.27
0.29%
17.04.26
17.04.26
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€46.75
27.12.23
27.12.23
€61.40
27.12.24
27.12.24
18.50%
28.12.24
28.12.24